School of Medicine
Showing 11-20 of 79 Results
-
Gloria M. Kardong MD, DLFAPA, DABPN
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioI attended Stanford University as an undergraduate, then returned to Stanford for my Psychiatry residency and Chief Residency. I then joined the Faculty in the Department of Psychiatry and Behavioral Sciences. I am an adjunct Clinical Associate Professor. I teach and supervise the residents in the program.
I am also on the Faculty of the Stanford Forensic Psychiatry Fellowship Program, where I teach and supervise post-graduate Fellows.
I have served an Examiner for the Medical Board of California and do Forensic Psychiatry/Expert Witness work for attorneys as part of my private practice for the past 15 years.
I have been in private practice for 35 years, including 15 years of virtual care. I am licensed in 10 states and can provide telepsychiatry services in all of those states.
Among my specialties are trauma; abuse; PTSD; women's health care-related issues, including pregnacy and post-partum issues, PMS, menopause and hormonal issues across the life span.
I also enjoy treating student health-related concerns and helping impaired professionals.
I treat all psychiatric problems for men, women, adolescents and couples. This includes anxiety, panic, bipolar disorder, ADHD, relationship issues and more. -
Krishna Govinda Kary (they/them)
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Krishna Kary (they/them) is a licensed psychologist who specializes in working with adolescents, adults, and couples within the LGBTQ+ community to address concerns related to depression, anxiety, sexuality, identity and interpersonal challenges. Dr. Kary received their PhD in Counseling Psychology from the Counseling, Clinical, and School Psychology program at the University of California, Santa Barbara. They received their MA and BS from Santa Clara University in Counseling and Psychology, respectively. Their clinical internship was completed at the University of California, Los Angeles Counseling and Psychological Services (CAPS) and their postdoctoral Gender and Sexual Identities fellowship at Stanford University CAPS. Dr. Kary serves patients through the THRIVE clinic at the Stanford School of Medicine and is emotion-focused, collaborative, and culturally-sensitive in their approach to psychotherapy. In addition to their interest in clinical care, they also enjoy supervision and training, teaching, and consultation related to gender inclusivity practices.
-
Max Kasun
Research Professional, Psychiatry and Behavioral Sciences
BioMax Kasun works in the Roberts Ethics Lab and Kim Ethics Lab at Stanford, which use empirical methods to help anticipate, clarify and resolve ethical issues in modern biomedical research. He received his BA from the University of Wisconsin-Madison. He has interests in empirical and normative thought dedicated to increasing scientific understanding and societal appreciation of the nature, internal experience, and prevalence of mental illness and well-being, as well as in moral philosophy (e.g. justice, action, capability, neo-Aristotelianism, and pragmatism), cognitive and affective sciences, and philosophy of mind (e.g. embodiment and personhood). He has co-authored scientific, peer-reviewed articles and other scholarly work investigating ethical issues in research (e.g. authentic voluntarism in informed consent), medical education, public health, and neuroscience. His most recent contributions to NIH-funded scientific work (National Center for Advancing Translational Sciences; PI: Dr. Jane Kim) have focused on investigating ethical issues encountered in the design, development, and clinical integration of artificial intelligence, e.g., how environmental and cognitive factors shape appraisals of AI tools, clinical judgments, trust, and health decision-making.
Max is a co-author of several chapters in APA's Study Guide to DSM-5-TR (2024) including the chapters on bipolar and related disorders and personality disorders. He has provided editorial support for the peer-reviewed journal Academic Medicine and for two works on the subject of trauma and related interventions (United Nations, Springer). Previously, he served on leadership teams for the Stanford Mental Health Technology and Innovation Hub and Neurodiversity Project.
Max is currently working to develop a new Special Initiative of the Chair on Mental Health Care for Unhoused and Justice-Involved Persons (see https://med.stanford.edu/psychiatry/special-initiatives/mhuj.html). The initiative aims to bring together a community of scholars, public stakeholders, and health care professionals to help advance more humane and participatory inquiry and health policy in service of a population that faces profound controversy, health stigma, and scientific neglect. The initiative aims to improve how science is communicated to the public and policy decision-makers and to develop more evidence-based, pragmatic, strengths-based, and trauma-informed approaches to mental health care for unhoused persons, including those who have experienced episodic or cyclical involvement in the criminal and civil justice systems. -
Makoto Kawai
Clinical Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioI am a physician scientist in the field of sleep medicine in aging and brain function. Using combined polysomnogram and novel neuroimaging technology, I aim to identify potential sleep biomarkers to investigate the mechanism of progression from normal aging to Mild Cognitive Impairment (MCI) or dementia. I also investigate the impact of sleep on cognitive/affective function or behavior abnormality in various neurodevelopmental and neurodegenerative disorders.
-
Debra Lee Kaysen
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsMuch of my current research focus is on the development of testing of accessible, scaleable, and effective treatments for trauma-related disorders and related comorbidities (e.g. substance use disorders, HIV, mood disorders). This work has focused on addressing trauma-related disorders especially in underserved populations and settings. This includes research in rural communities, with Native American communities, and with sexual minorities. My research has had a strong impact on building an evidence base on adaptations of psychotherapies for PTSD and substance use disorders for diverse populations both within and outside the United States. Our findings demonstrate that complex cognitive behavioral psychotherapies like Cognitive Processing Therapy can be culturally adapted and delivered in challenging settings (conflict settings, high poverty environments) with significant and lasting change in PTSD, depression, and functioning. This has led to work adapting CPT for diverse populations within the United States (rural Native Americans, urban Latinos) and outside of it (Iraq, DRC). Other research has focused on treatment for PTSD/SUD. My research has also found support for the use of brief telehealth interventions to build treatment engagement and to reduce drinking among trauma-exposed populations. In addition, my work has been critical in testing the feasibility of novel trauma-focused interventions for use by those with PTSD and SUD, thus paving the road for more rigorous research studies.
Current PI'ed research studies include: 1) developing and evaluating a brief motivational interviewing intervention designed to increase treatment-seeking among military personnel with untreated PTSD; a two-arm randomized comparative effectiveness trial to evaluate prevention of HIV/STI sexual risk behavior by addressing PTSD through Narrative Exposure Therapy or substance use through Motivational Interviewing among Native American men and women with PTSD; and 3) a comparison of outcomes among patients randomized to initially receive pharmacotherapy or Written Exposure Therapy delivered in primary care as well as comparing outcomes among patients randomized to treatment sequences (i.e., switching and augmenting) for patients who do not respond to the initial treatment.
